✦ LIBER ✦

Cost-effectiveness of novel relapsed-refractory multiple myeloma therapies in Norway: lenalidomide plus dexamethasone vs bortezomib

✍ Scribed by Möller, Jörgen; Nicklasson, Lars; Murthy, Ananthram

Book ID: 127209462
Publisher: Informa plc
Year: 2011
Tongue: English
Weight: 150 KB
Volume: 14
Category: Article
ISSN: 1369-6998
DOI: 10.3111/13696998.2011.611841

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy of thalidomide-based therapy fo

Efficacy of thalidomide-based therapy following lenalidomide plus dexamethasone in patients with relapsed/refractory multiple myeloma

✍ Kukreti, Vishal; Masih-Khan, Esther; Young, Trieu; Chu, Chia-Min; Jiang, Haiyun; 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

The cost-effectiveness of bortezomib in

The cost-effectiveness of bortezomib in relapsed/refractory multiple myeloma: Swedish perspective

✍ John Hornberger; Joseph Rickert; Ravinder Dhawan; Johan Liwing; Johan Aschan; Mi 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 144 KB

PCN48 THE COST-EFFECTIVENESS OF BORTEZOM

PCN48 THE COST-EFFECTIVENESS OF BORTEZOMIB FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA IN SWEDEN

✍ JB Rickert; J Hornberger; R Dhawan; J Liwing; J Aschan; M Lothgren 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB

Lenalidomide plus dexamethasone is more

Lenalidomide plus dexamethasone is more effective than dexamethasone alone in patients with relapsed or refractory multiple myeloma regardless of prior thalidomide exposure

✍ Wang, M.; Dimopoulos, M. A.; Chen, C.; Cibeira, M. T.; Attal, M.; Spencer, A.; R 📂 Article 📅 2008 🏛 American Society of Hematology 🌐 English ⚖ 159 KB

PSY39 REAL-WORLD COST-EFFECTIVENESS OF B

PSY39 REAL-WORLD COST-EFFECTIVENESS OF BORTEZOMIB IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA IN THE NETHERLANDS

✍ Gaultney, J; Franken, M; Huijgens, PC; Sonneveld, P; Uyl-De, Groot C; Redekop, W 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB

Effects of Lenalidomide and Dexamethason

Effects of Lenalidomide and Dexamethasone Treatment Duration on Survival in Patients With Relapsed or Refractory Multiple Myeloma Treated With Lenalidomide and Dexamethasone

✍ Jesús F. San-Miguel; Meletios A. Dimopoulos; Edward A. Stadtmauer; S. Vincent Ra 📂 Article 📅 2011 🏛 Elsevier 🌐 English ⚖ 208 KB